We demonstrated that, in contrast to classical opioid receptors, ACKR3 does not trigger classical G protein signaling and isn't modulated through the classical prescription or analgesic opioids, including morphine, fentanyl, or buprenorphine, or by nonselective opioid antagonists including naloxone. As a substitute, we established that LIH383, an ACKR3-selective subnanomolar https://russz924icw6.activablog.com/profile